Correlation between RAGE gene promoter methylation and diabetic retinal inflammation

Area of Science:

• Molecular Biology
• Genetics
• Immunology

Background:

• Diabetic retinopathy (DR) is a microvascular complication of diabetes.
• Inflammation plays a key role in the pathogenesis of DR.
• The receptor for advanced glycation end products (RAGE) is implicated in inflammatory processes.

Purpose of the Study:

• To investigate the methylation status of the RAGE gene promoter in peripheral blood mononuclear cells (PBMCs) of type 2 DR patients.
• To explore the correlation between RAGE gene promoter methylation and diabetic retinal inflammation.
• To assess the effect of RAGE gene promoter methylation inhibition on inflammatory markers.

Main Methods:

• Peripheral blood mononuclear cells (PBMCs) were collected from 80 type 2 DR patients and 40 healthy controls.
• RAGE gene promoter methylation status was analyzed using methylation-specific PCR (MSP).
• Serum levels of inflammatory cytokines (IL-1β, IL-6, TNF-α) were measured by ELISA.
• Inhibition of RAGE gene promoter methylation was achieved using 5'-aza-2'-deoxycytidine (5-aza-dC).

Main Results:

• RAGE gene promoter hypomethylation was observed in 32.50% of DR patients, while it was methylated in all healthy subjects.
• Serum levels of IL-1β, IL-6, and TNF-α were significantly lower in DR patients with RAGE gene promoter methylation compared to those without (p<0.01).
• Inhibition of RAGE gene promoter methylation using 5-aza-dC led to increased levels of IL-1β, IL-6, and TNF-α in PBMC culture supernatants.

Conclusions:

• RAGE gene promoter hypomethylation is detected in type 2 diabetic retinopathy patients.
• RAGE gene promoter methylation status is inversely correlated with diabetic retinal inflammation.
• RAGE gene promoter methylation may play a protective role by inhibiting diabetic retinal inflammation.